Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02308527
Title Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children (BEACON)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Birmingham
Indications

neuroblastoma

Therapies

Bevacizumab + Irinotecan + Temozolomide

Temozolomide + Topotecan

Bevacizumab + Temozolomide

Bevacizumab + Temozolomide + Topotecan

Dinutuximab beta + Temozolomide

Temozolomide

Dinutuximab beta + Temozolomide + Topotecan

Irinotecan + Temozolomide

Cyclophosphamide + Dinutuximab beta + Topotecan

Age Groups: child | adult
Covered Countries


No variant requirements are available.